Browsing by Subject "Lung cancer"
Now showing items 1-15 of 15
-
Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
(Brac University, 2024-07)Small cell lung cancer is the most aggressive form of cancer and its progression is very fast and quick. The NF-kB pathway and small cell lung cancer are connected to each other. Despite all the findings and the advanced ... -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
(BRAC University, 2018-09)Lung cancer is the most common cancer among men and women of Bangladesh. People who smoke for more than 10 years, expose to dusty environment, affect by infectious disease like tuberculosis, pneumonia and chronic obstructive ... -
A comparative study of lung cancer prediction using deep learning
(Brac University, 2022-09)At the point when cells in the body develop out of control, this is alluded to as cancerous development. Lung cancer is the term used to depict cancer that starts in the lungs. At first in the field, classifier-based ... -
Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
(Brac University, 2024-02)This work addresses computational approaches to non-small cell lung cancer (NSCLC) drug discovery, highlighting the vital part that molecular docking plays in the early stages of drug discovery. It demonstrates the ... -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
(Brac University, 2023-12)Researchers must prioritize non-small cell lung cancer clinical research due of its high mortality. Ongoing endeavors are being made to improve the accessibility, evaluation simplicity, and prediction accuracy of endpoints ... -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
(Brac University, 2023-03)The American Cancer Society estimates that lung cancer is the most common type of cancer and nearly 25% cancer deaths result from lung cancer, of which three subtypes account for 80% of cases. This is the rationale behind ... -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-01)Research is required in the area of non-small cell lung cancer, due to its widespread prevalence. Efforts to enhance the accessibility, evaluative simplicity, and prediction accuracy of endpoints in clinical trials are ... -
Immunotherapy in the Management of Lung Cancer
(Brac University, 2021-11)Among all the major cancer types, lung cancer is one of the most common as it holds a higher percentage of cancer related mortality and treating lung cancer is yet a challenge. Chemotherapy, radiation therapy, surgery ... -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-03)In spite of recent developments in cancer therapy that are specifically targeted, a frightening number of individuals still pass away every year from lung cancer around the world. Because of this, we decided to focus our ... -
Molecules associated with the development of lung cancer
(Brac University, 2023-01)Molecular association with lung cancer is one of the most important and a very primary queries to understand the molecular basis of lung cancer and its development mechanism. There are different factors involved with ... -
Potential of liposomes for the treatment of lung cancer- a review
(Brac University, 2023-01)Lung cancer is the leading cause of all cancer deaths worldwide among both men and women with symptoms of cough, airway obstruction and hemoptysis. Lung cancer can be divided into two subtypes which are known as small cell ... -
Protein biomarkers for Lung Cancer: a bioinformatic approach
(BRAC University, 2016-08)Lung cancer is one of the most occurring cancers around the world with increasing mortality rate and Bangladesh has a very high rate of lung cancer patient. Detection of lung cancer is not very easy process and quite ... -
A review on recent advances in drugs for lung cancer treatment
(Brac University, 2023-02)One of the predominant reasons for cancer-related fatalities worldwide is lung cancer. Existing drugs in the therapeutic landscape though beneficial are linked with various limitations. Overcoming these posed a major ... -
A review on targeted therapies for lung cancer
(Brac University, 2022-10)Lung cancer is one of the leading causes of cancer related deaths. The malignancy is marked by a bleak prognosis and poor clinical result, owing primarily to advanced stage at diagnosis, imposing a significant cost on ... -
Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
(© 2014 Asian Pacific Organization for Cancer Prevention, 2014)Background: The problem of cancer, especially lung cancer, is very acute in Bangladesh. The present study was conducted to evaluate the risk of lung cancer among Bangladeshi people based on hereditary, socio-economic and ...
